Shield Therapeutics plc (AIM:STX)

Shield Therapeutics Revenue

In the year 2024, Shield Therapeutics had annual revenue of $32.18M USD with 145.93% growth. Shield Therapeutics had revenue of $20.05M in the half year ending December 31, 2024, with 594.90% growth.

• Revenue: $32.18M
• Revenue Growth: +145.93%
• P/S Ratio: 2.25
• Revenue / Employee: $510.79K
• Employees: 63
• Market Cap: 57.81M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	32.18M	19.10M	145.93%
Dec 31, 2023	13.09M	7.59M	137.95%
Dec 31, 2022	5.50M	3.44M	167.35%
Dec 31, 2021	2.06M	-12.12M	-85.50%
Dec 31, 2020	14.18M	13.23M	1,389.24%